Practice question

Answer the question and get instant feedback.

HardADA Standards of Care (2025): CKD and Risk Management; KDIGO (2024): CKDNephrologydiabetic ckd (finerenone)

A 68-year-old with CKD and proteinuria has BP controlled and is on ACEi and SGLT2 inhibitor. Persistent UACR 900 mg/g. What additional renoprotective option is emerging per guidance?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.